Andrew J. Fromkin
Director · 2 filings · Latest: May 28, 2026
Immunovant, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IMVT | Andrew J. Fromkin | Director | May 28, 2026 | Sale | $33.51 | 221,951 | $7.4M | 74,382 | |
IMVT | Andrew J. Fromkin | Director | May 28, 2026 | Option Exercise | $8.22 | 196,601 | $1.6M | 296,333 | |
IMVT | ANDREW J FROMKIN | — | May 28, 2026 | Proposed Sale | $33.52 | 221,951 | $7.4M | — | |
IMVT | ANDREW J FROMKIN | — | Dec 1, 2025 | Proposed Sale | $24.15 | 22,249 | $537.3K | — | |
IMVT | ANDREW J FROMKIN | — | Mar 7, 2025 | Proposed Sale | $19.52 | 8,000 | $156.2K | — |